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FIG. 1. CTL generated by immunization of CBA/J (H-2k)mice with vaccinia virus or influenza virus lyse virus-infected, but not TNP-modified, H-2-matched target cells.
The TNP assays were incubated for 6 h, the virus assays for 12 h. These assays are, at least for the influenza system, approximately equivalent, since maximal antigenic expression on influenza-infected L cells does not occur until at least 5-6 h ai~r infection (see Fig. 3 ). Spontaneous 51Cr release for all target cells was less than 25%.
immunization, 10 e mean tissue culture infective doses of vaccinia virus was inoculated intravenously into mice and their spleens were harvested 6 days later (13) . TNP-immune CTL were generated by culturing normal spleen cells for 5 days in vitro with irradiated TNP-modified syngeneic spleen cells as described by Burakoff et al. (11) .
Cytotoxicity Assay. Cytotexicity against 51Cr-labeled influenza-and vaccinia-infected L929 fibroblasts (C3H L cells, H-2 k) and MC57G sarcoma cells (C57BL/6, H-2 ~) was measured as outlined in detail elsewhere (12) . For TNP modification, 1-2 x 107 cells were reacted with 150 ~1 of 2.5 mM trinitrobenzene sulfonic acid in phosphate-buffered saline, pH 7.2, for 10 rain at 37°C, washed, and labeled with Na2 s~CrO~. Results are expressed as percent specific s]Cr release (12) and are the means of quadruplicate determinations.
Results and Discussion
The results in Fig. 1 and Table I demonstrate that TNP-modified L cells are lysed by TNP-immune but not influenza-or vaccinia-immune H-2 compatible lymphocyte populations. Target cells which were first modified with TNP and then infected with influenza virus were killed by both TNP-and influenzaimmune CTL (Table I) , but not by H-2 incompatible virus-immune effector cells. Furthermore, competitive inhibition experiments clearly demonstrated that anti-TNP and anti-influenza CTL were specific for the antigens used for sensitization (Fig. 2) .
Therefore, saturation of the plasma membrane with TNP does not detectably inhibit the capacity of influenza virus to infect cells or to induce the expression of antigen(s) which are recognized by influenza-immune CTL. These results do not simply reflect binding of the influenza virus inoculum to which the cells were exposed, since maximal antigenic expression at the plasma membrane is only observed 5-6 h after exposure to virus (Fig. 3) . Also, since influenza virus is a potent inhibitor of host cell protein synthesis ( In the present study, we have been unable to demonstrate any lysis of TNPmodified target cells by CTL from mice immunized with either vaccinia or influenza virus. Target cells which were modified with TNP and then infected with influenza virus expressed distinct cell surface antigens recognized by TNPand influenza-immune CTL. These results indicate that if altered-self antigens exist as a complex between nonself and H-2 (16), there is probably more than one reactive site on the H-2 molecule. If TNP-and virus-immune CTL do not recognize TNP molecules or viral components but are reactive to specific conformational changes in H-2K or D molecules induced by these agents, H-2K or D molecules must then be able to simultaneously express at least two distinct alterations. An alternative (17) (18) (19) is that individual T cells express two distinct receptors with specificity for self (H-2) and nonself (virus or TNP).
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Summary
Cytotoxic thymus-derived lymphocytes generated after interaction with trinitrophenyl (TNP)-substituted or virus-infected cells only lyse H-2 compatible target cells modified with the component used to immunize (TNP or virus). Prior saturation of TNP-reactive sites inhibits neither the infectivity of influenza A viruses, nor the capacity of infected cells to develop antigenic changes recognized by influenza-immune T cells. The two antigens are distinct entities on the cell membrane and do not obviously compete to form interactions with H-2 molecules.
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